Advertisement

Prevention of postpartum hemorrhage in vaginal deliveries

Published:November 23, 2022DOI:https://doi.org/10.1016/j.ejogrb.2022.11.021

      Abstract

      Identification of patients at risk for postpartum hemorrhage (PPH) may allow for prompt diagnosis and intervention. Individual risk factors, risk assessment tools and prediction models have been used for determining a patient’s risk of PPH. Measures for the prevention of PPH include identification and management of iron deficiency anemia, unit readiness and preparedness through performing regular simulations and having a PPH cart or medication kit readily available, prophylactic uterotonic - carbetocin alone or dual agents such as oxytocin and misoprostol or oxytocin and methylergometrine or antifibrinolytic (oxytocin and tranexamic acid) use in the third stage of labor immediately after fetal head delivery, and controlled cord traction.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References:

      1. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168-e186. doi:10.1097/AOG.0000000000002351.

        • Say L.
        • Chou D.
        • Gemmill A.
        • Tunçalp Ö.
        • Moller A.-B.
        • Daniels J.
        • et al.
        Global causes of maternal death: A WHO systematic analysis.
        Lancet Glob Health. 2014; 2: e323-e333
      2. Pregnancy Mortality Surveillance System | Maternal and Infant Health | CDC. Published April 13, 2022. Accessed May 18, 2022. https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm.

        • Lipkind H.S.
        • Zuckerwise L.C.
        • Turner E.B.
        • Collins J.J.
        • Campbell K.H.
        • Reddy U.M.
        • et al.
        Severe maternal morbidity during delivery hospitalisation in a large international administrative database, 2008–2013: A retrospective cohort.
        BJOG Int J Obstet Gynaecol. 2019; 126: 1223-1230
        • Goad L.
        • Rockhill K.
        • Schwarz J.
        • Heyborne K.
        • Fabbri S.
        Development and validation of a prediction model for postpartum hemorrhage at a single safety net tertiary care center.
        Am J Obstet Gynecol MFM. 2021; 3100404https://doi.org/10.1016/j.ajogmf.2021.100404
        • Bingham D.
        • Melsop K.
        • Main E.
        CMQCC Obstetric Hemorrhage Hospital Level Implementation Guide.
        Stanford University, Palo Alto, CA, The California Maternal Quality Care Collaborative (CMQCC)2010
        • Dilla A.J.
        • Waters J.H.
        • Yazer M.H.
        Clinical validation of risk stratification criteria for peripartum hemorrhage.
        Obstet Gynecol. 2013; 122: 120-126https://doi.org/10.1097/AOG.0b013e3182941c78
      3. Association of Women’s Health Obstetric and Neonatal Nurses. Postpartum Hemorrhage Project: A Multi-Hospital Quality Improvement Program.https://www.awhonn.org/postpartum-hemorrhage-pph/. Accessed May 11, 2022.

      4. American Congress of Obstetricians and Gynecologists. Maternal safety bundle for obstetric hemorrhage. Available at: https://www.acog.org/-/media/project/acog/acogorg/files/forms/districts/smi-ob-hemorrhage-bundle-slides.pdf. Accessed May 11, 2022.

        • Colalillo E.L.
        • Sparks A.D.
        • Phillips J.M.
        • Onyilofor C.L.
        • Ahmadzia H.K.
        Obstetric hemorrhage risk assessment tool predicts composite maternal morbidity.
        Sci Rep. 2021; 11: 14709https://doi.org/10.1038/s41598-021-93413-3
        • Al-Zirqi I.
        • Vangen S.
        • Forsen L.
        • Stray-Pedersen B.
        Prevalence and risk factors of severe obstetric haemorrhage.
        BJOG Int J Obstet Gynaecol. 2008; 115: 1265-1272https://doi.org/10.1111/j.1471-0528.2008.01859.x
        • Oyelese Y.
        • Ananth C.V.
        Postpartum hemorrhage: Epidemiology, risk factors, and causes.
        Clin Obstet Gynecol. 2010; 53: 147-156https://doi.org/10.1097/GRF.0b013e3181cc406d
        • Combs C.A.
        • Murphy E.L.
        • Laros R.K.
        Factors associated with postpartum hemorrhage with vaginal birth.
        Obstet Gynecol. 1991; 77: 69-76
        • Sheiner E.
        • Sarid L.
        • Levy A.
        • Seidman D.S.
        • Hallak M.
        Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: A population-based study.
        J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2005; 18: 149-154https://doi.org/10.1080/14767050500170088
        • Sosa C.G.
        • Althabe F.
        • Belizán J.M.
        • Buekens P.
        Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population.
        Obstet Gynecol. 2009; 113: 1313-1319https://doi.org/10.1097/AOG.0b013e3181a66b05
        • Helman S.
        • Drukker L.
        • Fruchtman H.
        • Ioscovich A.
        • Farkash R.
        • Avitan T.
        • et al.
        Revisit of risk factors for major obstetric hemorrhage: Insights from a large medical center.
        Arch Gynecol Obstet. 2015; 292: 819-828
        • Kramer M.S.
        • Berg C.
        • Abenhaim H.
        • Dahhou M.
        • Rouleau J.
        • Mehrabadi A.
        • et al.
        Incidence, risk factors, and temporal trends in severe postpartum hemorrhage.
        Am J Obstet Gynecol. 2013; 209
        • Driessen M.
        • Bouvier-Colle M.-H.
        • Dupont C.
        • Khoshnood B.
        • Rudigoz R.-C.
        • Deneux-Tharaux C.
        Postpartum hemorrhage resulting from uterine atony after vaginal delivery: Factors associated with severity.
        Obstet Gynecol. 2011; 117: 21-31
        • Wetta L.A.
        • Szychowski J.M.
        • Seals S.
        • Mancuso M.S.
        • Biggio J.R.
        • Tita A.T.N.
        Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery.
        Am J Obstet Gynecol. 2013; 209https://doi.org/10.1016/j.ajog.2013.03.011
        • Koopmans C.M.
        • van der Tuuk K.
        • Groen H.
        • Doornbos J.P.R.
        • de Graaf I.M.
        • van der Salm P.C.M.
        • et al.
        Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term.
        Acta Obstet Gynecol Scand. 2014; 93: 399-407
        • Kawakita T.
        • Mokhtari N.
        • Huang J.C.
        • Landy H.J.
        Evaluation of risk-assessment tools for severe postpartum hemorrhage in women undergoing cesarean delivery.
        Obstet Gynecol. 2019; 134: 1308-1316https://doi.org/10.1097/AOG.0000000000003574
        • Liu C.
        • Xu Y.
        • Li J.
        • Guan Z.
        • Liu C.
        • He F.
        Development and validation of a predictive model for severe postpartum hemorrhage in women undergoing vaginal delivery: A retrospective cohort study.
        Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2022; 157: 353-358https://doi.org/10.1002/ijgo.13797
        • Rubio-Álvarez A.
        • Molina-Alarcón M.
        • Arias-Arias Á.
        • Hernández-Martínez A.
        Development and validation of a predictive model for excessive postpartum blood loss: A retrospective, cohort study.
        Int J Nurs Stud. 2018; 79: 114-121https://doi.org/10.1016/j.ijnurstu.2017.11.009
        • Bose P.
        • Regan F.
        • Paterson-Brown S.
        Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions.
        BJOG Int J Obstet Gynaecol. 2006; 113: 919-924https://doi.org/10.1111/j.1471-0528.2006.01018.x
        • Razvi K.
        • Chua S.
        • Arulkumaran S.
        • Ratnam S.S.
        A comparison between visual estimation and laboratory determination of blood loss during the third stage of labour.
        Aust N Z J Obstet Gynaecol. 1996; 36: 152-154https://doi.org/10.1111/j.1479-828x.1996.tb03273.x
        • Neary C.
        • Naheed S.
        • McLernon D.J.
        • Black M.
        Predicting risk of postpartum haemorrhage: A systematic review.
        BJOG Int J Obstet Gynaecol. 2021; 128: 46-53https://doi.org/10.1111/1471-0528.16379
        • Pressly M.A.
        • Parker R.S.
        • Waters J.H.
        • Beck S.L.
        • Jeyabalan A.
        • Clermont G.
        Improvements and limitations in developing multivariate models of hemorrhage and transfusion risk for the obstetric population.
        Transfusion (Paris). 2021; 61: 423-434https://doi.org/10.1111/trf.16216
        • Venkatesh K.K.
        • Strauss R.A.
        • Grotegut C.A.
        • Heine R.P.
        • Chescheir N.C.
        • Stringer J.S.A.
        • et al.
        Machine learning and statistical models to predict postpartum hemorrhage.
        Obstet Gynecol. 2020; 135: 935-944
        • Lao T.T.
        • Wong L.L.
        • Hui S.Y.A.
        • Sahota D.S.
        Iron deficiency anaemia and atonic postpartum haemorrhage following labour.
        Reprod Sci. 2022; 29: 1102-1110
        • Omotayo M.O.
        • Abioye A.I.
        • Kuyebi M.
        • Eke A.C.
        Prenatal anemia and postpartum hemorrhage risk: A systematic review and meta-analysis.
        J Obstet Gynaecol Res. 2021; 47: 2565-2576https://doi.org/10.1111/jog.14834
      5. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Anemia in Pregnancy: ACOG Practice Bulletin, Number 233. Obstet Gynecol. 2021;138(2):e55-e64. doi:10.1097/AOG.0000000000004477.

        • Govindappagari S.
        • Burwick R.M.
        Treatment of iron deficiency anemia in pregnancy with intravenous versus oral iron: Systematic review and meta-analysis.
        Am J Perinatol. 2019; 36: 366-376https://doi.org/10.1055/s-0038-1668555
        • Dillon S.J.
        • Kleinmann W.
        • Fomina Y.
        • Werner B.
        • Schultz S.
        • Klucsarits S.
        • et al.
        Does simulation improve clinical performance in management of postpartum hemorrhage?.
        Am J Obstet Gynecol. 2021; 225
        • Committee opinion no
        590: preparing for clinical emergencies in obstetrics and gynecology.
        Obstet Gynecol. 2014; 123: 722-725https://doi.org/10.1097/01.AOG.0000444442.04111.c6
        • Kogutt B.K.
        • Kim J.M.
        • Will S.E.
        • Sheffield J.S.
        Development of an obstetric hemorrhage response intervention: The postpartum hemorrhage cart and medication kit.
        Jt Comm J Qual Patient Saf. 2022; 48: 120-128https://doi.org/10.1016/j.jcjq.2021.09.007
        • Begley C.M.
        • Gyte G.M.
        • Devane D.
        • McGuire W.
        • Weeks A.
        • Biesty L.M.
        Active versus expectant management for women in the third stage of labour.
        Cochrane Database Syst Rev. 2019; 2: CD007412https://doi.org/10.1002/14651858.CD007412.pub5
        • Frolova A.I.
        • Stout M.J.
        • Tuuli M.G.
        • López J.D.
        • Macones G.A.
        • Cahill A.G.
        Duration of the third stage of labor and risk of postpartum hemorrhage.
        Obstet Gynecol. 2016; 127: 951-956https://doi.org/10.1097/AOG.0000000000001399
        • Magann E.F.
        • Evans S.
        • Chauhan S.P.
        • Lanneau G.
        • Fisk A.D.
        • Morrison J.C.
        The length of the third stage of labor and the risk of postpartum hemorrhage.
        Obstet Gynecol. 2005; 105: 290-293https://doi.org/10.1097/01.AOG.0000151993.83276.70
        • Gallos I.
        • Williams H.
        • Price M.
        • et al.
        Uterotonic agents for preventing postpartum haemorrhage: A network meta-analysis.
        Cochrane Database Syst Rev. 2018; : (4)https://doi.org/10.1002/14651858.CD011689.pub2.www.cochranelibrary.com
        • Adnan N.
        • Conlan-Trant R.
        • McCormick C.
        • Boland F.
        • Murphy D.J.
        Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: Randomised controlled trial.
        BMJ. 2018; 362k3546https://doi.org/10.1136/bmj.k3546
        • Oladapo O.T.
        • Okusanya B.O.
        • Abalos E.
        • Gallos I.D.
        • Papadopoulou A.
        Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour.
        Cochrane Database Syst Rev. 2020; 11: CD009332https://doi.org/10.1002/14651858.CD009332.pub4
        • Charles D.
        • Anger H.
        • Dabash R.
        • Darwish E.
        • Ramadan M.C.
        • Mansy A.
        • et al.
        Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: A three-arm randomized control trial.
        BMC Pregnancy Childbirth. 2019; 19
        • Oladapo O.T.
        • Okusanya B.O.
        • Abalos E.
        Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour.
        Cochrane Database Syst Rev. 2018; 9: CD009332https://doi.org/10.1002/14651858.CD009332.pub3
        • Durocher J.
        • Dzuba I.G.
        • Carroli G.
        • et al.
        Does route matter? Impact of route of oxytocin administration on postpartum bleeding: A double-blind, randomized controlled trial.
        PLoS One. 2019; 14: 1-13https://doi.org/10.7910/DVN/MDZRKU.Funding
        • Davies G.A.L.
        • Tessier J.L.
        • Woodman M.C.
        • Lipson A.
        • Hahn P.M.
        Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: A randomized controlled trial.
        Obstet Gynecol. 2005; 105: 294-299https://doi.org/10.1097/01.AOG.0000148264.20909.bb
        • Pinder A.J.
        • Dresner M.
        • Calow C.
        • Shorten G.D.
        • O’Riordan J.
        • Johnson R.
        Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia.
        Int J Obstet Anesth. 2002; 11: 156-159https://doi.org/10.1054/ijoa.2002.0970
        • Thomas J.S.
        • Koh S.H.
        • Cooper G.M.
        Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section.
        Br J Anaesth. 2007; 98: 116-119https://doi.org/10.1093/bja/ael302
        • Mori R.
        • Nardin J.M.
        • Yamamoto N.
        • Carroli G.
        • Weeks A.
        Umbilical vein injection for the routine management of third stage of labour.
        Cochrane Database Syst Rev. 2012; : (3)https://doi.org/10.1002/14651858.CD006176.pub2
        • Salati J.A.
        • Leathersich S.J.
        • Williams M.J.
        • Cuthbert A.
        • Tolosa J.E.
        Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
        Cochrane Database Syst Rev. 2019; 2019https://doi.org/10.1002/14651858.CD001808.pub3
        • Tita A.T.N.
        • Szychowski J.M.
        • Rouse D.J.
        • Bean C.M.
        • Chapman V.
        • Nothern A.
        • et al.
        Higher-dose oxytocin and hemorrhage after vaginal delivery: A randomized controlled trial.
        Obstet Gynecol. 2012; 119: 293-300
        • Soltani H.
        • Hutchon D.R.
        • Poulose T.A.
        Timing of prophylactic uterotonics for the third stage of labour after vaginal birth.
        Cochrane Database Syst Rev. 2010; 8: CD006173https://doi.org/10.1002/14651858.CD006173.pub2
        • Jackson K.W.
        • Allbert J.R.
        • Schemmer G.K.
        • Elliot M.
        • Humphrey A.
        • Taylor J.
        A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage.
        Am J Obstet Gynecol. 2001; 185: 873-877https://doi.org/10.1067/mob.2001.117363
        • Hoffman M.
        • Castagnola D.
        • Naqvi F.
        A randomized trial of active versus expectant management of the third stage of labor.
        Am J Obstet Gynecol. 2006; 195: S107https://doi.org/10.1016/j.ajog.2006.10.358
        • Yildirim D.
        • Ozyurek S.E.
        Intramuscular oxytocin administration before vs. after placental delivery for the prevention of postpartum hemorrhage: A randomized controlled prospective trial.
        Eur J Obstet Gynecol Reprod Biol. 2018; 224: 47-51https://doi.org/10.1016/j.ejogrb.2018.03.012
        • Oguz Orhan E.
        • Dilbaz B.
        • Aksakal S.E.
        • Altınbas S.
        • Erkaya S.
        Prospective randomized trial of oxytocin administration for active management of the third stage of labor.
        Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2014; 127: 175-179https://doi.org/10.1016/j.ijgo.2014.05.022
        • Saccone G.
        • Della Corte L.
        • D’Alessandro P.
        • Ardino B.
        • Carbone L.
        • Raffone A.
        • et al.
        Prophylactic use of tranexamic acid after vaginal delivery reduces the risk of primary postpartum hemorrhage.
        J Matern Fetal Neonatal Med. 2020; 33: 3368-3376
        • Novikova N.
        • Hofmeyr G.J.
        • Cluver C.
        Tranexamic acid for preventing postpartum haemorrhage.
        Cochrane Database Syst Rev. 2015; : (6)https://doi.org/10.1002/14651858.CD007872.pub3
        • Gungorduk K.
        • Asıcıoğlu O.
        • Yıldırım G.
        • Ark C.
        • Tekirdağ A.İ.
        • Besımoglu B.
        Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study.
        Am J Perinatol. 2013; 30: 407-413https://doi.org/10.1055/s-0032-1326986
        • Shakur H.
        • Roberts I.
        • Fawole B.
        • Chaudhri R.
        • El-Sheikh M.
        • Akintan A.
        • et al.
        Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
        Lancet Lond Engl. 2017; 389: 2105-2116
        • Sentilhes L.
        • Winer N.
        • Azria E.
        • Sénat M.-V.
        • Le Ray C.
        • Vardon D.
        • et al.
        Tranexamic acid for the prevention of blood loss after vaginal delivery.
        N Engl J Med. 2018; 379: 731-742
        • Taeuber I.
        • Weibel S.
        • Herrmann E.
        • Neef V.
        • Schlesinger T.
        • Kranke P.
        • et al.
        Association of intravenous tranexamic acid with thromboembolic events and mortality: A systematic review, meta-analysis, and meta-regression.
        JAMA Surg. 2021; 156: e210884
        • Chaudhuri P.
        • Majumdar A.
        A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
        Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2016; 132: 191-195https://doi.org/10.1016/j.ijgo.2015.06.064
        • Awoleke J.O.
        • Adeyanju B.T.
        • Adeniyi A.
        • Aduloju O.P.
        • Olofinbiyi B.A.
        Randomised controlled trial of sublingual and rectal misoprostol in the prevention of primary postpartum haemorrhage in a resource-limited community.
        J Obstet Gynecol India. 2020; 70: 462-470https://doi.org/10.1007/s13224-020-01338-0
        • Ugwu I.A.
        • Oluwasola T.A.
        • Enabor O.O.
        • Anayochukwu-Ugwu N.N.
        • Adeyemi A.B.
        • Olayemi O.O.
        Randomized controlled trial comparing 200 μg and 400 μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
        Int J Gynecol Obstet. 2016; 133: 173-177https://doi.org/10.1016/j.ijgo.2015.09.026
        • Parry Smith W.R.
        • Papadopoulou A.
        • Thomas E.
        • Tobias A.
        • Price M.J.
        • Meher S.
        • et al.
        Uterotonic agents for first-line treatment of postpartum haemorrhage: A network meta-analysis.
        Cochrane Database Syst Rev. 2020; 2020: 11https://doi.org/10.1002/14651858.CD012754.pub2
        • Elati A.
        • Weeks A.
        Risk of fever after misoprostol for the prevention of postpartum hemorrhage: A meta-analysis.
        Obstet Gynecol. 2012; 120: 1140-1148https://doi.org/10.1097/aog.0b013e3182707341
        • Elati A.
        • Elmahaishi M.S.
        • Elmahaishi M.O.
        • Elsraiti O.A.
        • Weeks A.D.
        The effect of misoprostol on postpartum contractions: A randomised comparison of three sublingual doses.
        BJOG Int J Obstet Gynaecol. 2011; 118: 466-473https://doi.org/10.1111/j.1471-0528.2010.02821.x
        • Lagrew D.
        • McNulty J.
        • Sakowski C.
        • et al.
        Improving health care response to obstetric hemorrhage, a california maternal quality care collaborative toolkit.
        Published online. 2022;
        • Dahlke J.D.
        • Mendez-Figueroa H.
        • Maggio L.
        • Hauspurg A.K.
        • Sperling J.D.
        • Chauhan S.P.
        • et al.
        Prevention and management of postpartum hemorrhage: A comparison of 4 national guidelines.
        Am J Obstet Gynecol. 2015; 213
      6. G.J. Hofmeyr N.T. Mshweshwe A.M. Gülmezoglu Controlled cord traction for the third stage of labour Cochrane Database Syst Rev. 2015;1(1):CD008020. 10.1002/14651858.CD008020.pub2.

        • Du Y.
        • Ye M.
        • Zheng F.
        Active management of the third stage of labor with and without controlled cord traction: A systematic review and meta-analysis of randomized controlled trials.
        Acta Obstet Gynecol Scand. 2014; 93: 626-633https://doi.org/10.1111/aogs.12424
      7. American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Delayed Umbilical Cord Clamping After Birth: ACOG Committee Opinion, Number 814. Obstet Gynecol. 2020;136(6):e100-e106. doi:10.1097/AOG.0000000000004167.

      8. S.J. McDonald P. Middleton T. Dowswell P.S. Morris Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes Cochrane Database Syst Rev. 2013;(7):CD004074. 10.1002/14651858.CD004074.pub3.

        • Andersson O.
        • Lindquist B.
        • Lindgren M.
        • Stjernqvist K.
        • Domellöf M.
        • Hellström-Westas L.
        Effect of delayed cord clamping on neurodevelopment at 4 years of age: A randomized clinical trial.
        JAMA Pediatr. 2015; 169: 631-638https://doi.org/10.1001/jamapediatrics.2015.0358
        • Al-Wassia H.
        • Shah P.S.
        Efficacy and safety of umbilical cord milking at birth: A systematic review and meta-analysis.
        JAMA Pediatr. 2015; 169: 18-25https://doi.org/10.1001/jamapediatrics.2014.1906
        • Jeevan A.
        • Ananthan A.
        • Bhuwan M.
        • Balasubramanian H.
        • Rao S.
        • Kabra N.S.
        Umbilical cord milking versus delayed cord clamping in term and late-preterm infants: A systematic review and meta-analysis.
        J Matern Fetal Neonatal Med. 2022; 35: 5478-5488
        • Fuwa K.
        • Tabata N.
        • Ogawa R.
        • Nagano N.
        • Yamaji N.
        • Ota E.
        • et al.
        Umbilical cord milking versus delayed cord clamping in term infants: A systematic review and meta-analysis.
        J Perinatol. 2021; 41: 1549-1557
      9. Effects of cord milking in late preterm infants and full‐term infants: A systematic review and meta‐analysis. Accessed October 27, 2021. https://onlinelibrary-wiley-com.proxy1.library.jhu.edu/doi/epdf/10.1111/birt.12500.

        • Katheria A.
        • Reister F.
        • Essers J.
        • Mendler M.
        • Hummler H.
        • Subramaniam A.
        • et al.
        Association of umbilical cord milking vs delayed umbilical cord clamping with death or severe intraventricular hemorrhage among preterm infants.
        JAMA. 2019; 322: 1877
        • Upadhyay A.
        • Gothwal S.
        • Parihar R.
        • Garg A.
        • Gupta A.
        • Chawla D.
        • et al.
        Effect of umbilical cord milking in term and near term infants: Randomized control trial.
        Am J Obstet Gynecol. 2013; 208
        • Saccone G.
        • Caissutti C.
        • Ciardulli A.
        • Abdel-Aleem H.
        • Hofmeyr G.J.
        • Berghella V.
        Uterine massage as part of active management of the third stage of labour for preventing postpartum haemorrhage during vaginal delivery: A systematic review and meta-analysis of randomised trials.
        BJOG. 2018; 125: 778-781https://doi.org/10.1111/1471-0528.14923
      10. G.J. Hofmeyr H. Abdel-Aleem M.A. Abdel-Aleem Uterine massage for preventing postpartum haemorrhage Cochrane Database Syst Rev. 2013;(7):CD006431. 10.1002/14651858.CD006431.pub3.

        • Kim Y.M.
        • Tejani N.
        • Chayen B.
        • Verma U.L.
        Management of the third stage of labor with nipple stimulation.
        J Reprod Med. 1986; 31: 1033-1034
        • Dashtinejad E.
        • Abedi P.
        • Afshari P.
        Comparison of the effect of breast pump stimulation and oxytocin administration on the length of the third stage of labor, postpartum hemorrhage, and anemia: A randomized controlled trial.
        BMC Pregnancy Childbirth. 2018; 18: 293https://doi.org/10.1186/s12884-018-1832-z
        • Alfirevic Z.
        • Elbourne D.
        • Pavord S.
        • Bolte A.
        • Van Geijn H.
        • Mercier F.
        • et al.
        Use of recombinant activated factor VII in primary postpartum hemorrhage: The Northern European registry 2000–2004.
        Obstet Gynecol. 2007; 110: 1270-1278
        • Kobayashi T.
        • Nakabayashi M.
        • Yoshioka A.
        • Maeda M.
        • Ikenoue T.
        Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: Initial report of a multicentre case series in Japan.
        Int J Hematol. 2012; 95: 57-63https://doi.org/10.1007/s12185-011-0974-9
        • Levi M.
        • Levy J.H.
        • Andersen H.F.
        • Truloff D.
        Safety of recombinant activated factor VII in randomized clinical trials.
        N Engl J Med. 2010; 363: 1791-1800https://doi.org/10.1056/NEJMoa1006221